IR-MED Appoints Ran Ziskind, Tech Entrepreneur, Growth Manager, and Inventor as Chief Executive Officer
August 28, 2024 09:15 ET
|
IR-Med, Inc.
Rosh Pina, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- IR-MED Inc., (“IR-MED” or the “Company”) (OTCQB:IRME), developer of a noninvasive artificial intelligence (AI) driven spectrographic analysis...
IR-MED’s AI-Powered Infra-Red Spectrographic Decision Support System PressureSafe Device Demonstrates High Efficacy in Detecting Pressure Injuries with 96% Accuracy: Potential to Set a New Standard of Care
July 17, 2023 09:15 ET
|
IR-Med, Inc.
IR-MED to file for FDA approval Q4 2023 with U.S. market launch expected in H1 20242.5 million patients develop pressure injuries and 60,000 die annually as a direct result; $26.8 billion is spent...
IR-Med to present at National Pressure Injury Advisory Panel 2023
March 14, 2023 09:00 ET
|
IR-Med, Inc.
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) -- “IR-MED” or the...